Fcgamma receptor polymorphisms as biomarkers for epidermal growth factor receptor antibodies

Comment

Thomas Valerius. J Clin Oncol. 2010.

. 2010 Aug 10;28(23):e393; author reply e394-6.

doi: 10.1200/JCO.2010.28.7342. Epub 2010 Jun 14.

No abstract available

Comment on

Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA, Tsao MS. Shepherd FA, et al. J Clin Oncol. 2010 Feb 20;28(6):903-5. doi: 10.1200/JCO.2009.26.3996. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100955 No abstract available.
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.
Khambata-Ford S, Harbison CT, Hart LL, Awad M, Xu LA, Horak CE, Dakhil S, Hermann RC, Lynch TJ, Weber MR. Khambata-Ford S, et al. J Clin Oncol. 2010 Feb 20;28(6):918-27. doi: 10.1200/JCO.2009.25.2890. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100958 Clinical Trial.